Myriad Genetics (MYGN) – Analyst Ratings
-
Myriad Genetics (MYGN) PT Raised to $28 at Raymond James
-
Piper Sandler Starts Myriad Genetics (MYGN) at Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MYGN Stock Lookup